Novo Nordisk (NVO) or Eli Lilly (LLY)? Jim Cramer Gives a Clear Response

insidermonkey.com · 2026-10-08

During the October 1 lightning round of Mad Money, a caller said they owned both Novo Nordisk A/S (NYSE:NVO) and Eli Lilly and Company (NYSE:LLY).

TickrTrends take: Jim Cramer's comparison of Novo Nordisk and Eli Lilly highlights investor interest in distinguishing between major players in the weight-loss and diabetes treatment markets. Given TickrTrends' current undervalued assessment of LLY in the Healthcare sector, investors monitoring the company's valuation should observe how competitive positioning against NVO affects market pricing and whether current valuations adequately reflect LLY's market opportunities. The analyst commentary underscores that valuation conclusions require attention to both absolute pricing levels and relative competitive dynamics within the sector.

Read the full story at insidermonkey.com →